| [1] |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版)[J]. 中华结核和呼吸杂志, 2021, 44(3): 170-205. doi:10.3760/cma.j.cn112147-20210109-00031.
|
| [2] |
罗倩, 王晓园, 张海涛, 等. 新疆乌鲁木齐市城乡40岁以上居民慢性阻塞性肺疾病的患病情况与相关危险因素分析[J]. 临床肺科杂志, 2019, 24(9): 1562-1567. doi:10.3969/j.issn.1009-6663.2019.09.003.
|
| [3] |
夏宇, 考吾沙尔·巴合提江. 应用宏基因组二代测序技术分析慢性阻塞性肺疾病患者合并下呼吸道感染的BALF中微生物群落分布和载量[J]. 中国呼吸与危重监护杂志, 2024, 23(6): 414-422. doi:10.7507/1671-6205.202312059.
|
| [4] |
朱鸣雷, 刘晓红, 董碧蓉, 等. 老年共病管理中国专家共识(2023)[J]. 中国临床保健杂志, 2023, 26(5): 577-584. doi:10.3969/J.issn.1672-6790.2023.05.001.
|
| [5] |
张丽, 李耘, 钱玉英, 等. 老年共病的现状及研究进展[J]. 中华老年多器官疾病杂志, 2021, 20(1): 67-71. doi:10.11915/j.issn.1671-5403.2021.01.015.
|
| [6] |
Fabbri L M, Celli B R, Agustí A, et al. COPD and multimorbidity: recognising and addressing a syndemic occurrence[J]. Lancet Respir Med, 2023, 11(11): 1020-1034. doi:10.1016/S2213-2600(23)00261-8.
pmid: 37696283
|
| [7] |
Sethi S, Mahler D A, Marcus P, et al. Inflammation in COPD: implications for management[J]. Am J Med, 2012, 125(12): 1162-1170. doi:10.1016/j.amjmed.2012.06.024.
pmid: 23164484
|
| [8] |
Fu Y, Wang Y, Wang Y, et al. Biomarkers (NLR, PLR, SII) for frequent COPD exacerbations: diagnostic and clinical management implications in a retrospective study[J]. Int J Chron Obstruct Pulmon Dis, 2025, 20: 987-998. doi:10.2147/COPD.S510118.
|
| [9] |
Yi Q, Chen X, Liu S, et al. Systemic immune-inflammation index is associated with adverse outcomes in patients hospitalized for AECOPD: a multicenter cohort study[J]. Respiration, 2025, 104(9): 648-666. doi:10.1159/000545267.
pmid: 40233725
|
| [10] |
慢性阻塞性肺疾病急性加重诊治专家组. 慢性阻塞性肺疾病急性加重诊治中国专家共识(2023年修订版)[J]. 国际呼吸杂志, 2023, 43(2): 132-149. doi:10.3760/cma.j.cn131368-20221123-01066.
|
| [11] |
朱丹, 陈燕, 双庆翠, 等. 慢性阻塞性肺疾病急性加重期与慢性阻塞性肺疾病合并社区获得性肺炎的临床观察性分析[J]. 结核与肺部疾病杂志, 2022, 3(2): 118-124. doi:10.19983/j.issn.2096-8493.20210166.
|
| [12] |
秦田田, 徐超, 张起, 等. 慢性阻塞性肺疾病急性加重期患者炎症细胞表型与临床病理特征的相关性研究[J]. 数理医药学杂志, 2023, 36(7): 518-523. doi:10.12173/j.issn.1004-4337.202305149.
|
| [13] |
杨海燕, 努尔孜巴·艾力, 杜奭珺, 等. NLR、PLR、RDW、FIB新型炎症指标在细菌感染性AECOPD中的临床价值[J]. 热带医学杂志, 2025, 25(12): 1633-1638. doi:10.3969/j.issn.1672-3619.2025.12.006.
|
| [14] |
Ma J, Zhu X, Tang Q, et al. Epidemiological characteristics of respiratory diseases in emergency department patients from different ethnic groups in the Atushi region, Xinjiang[J]. Front Med(Lausanne), 2025, 12: 1569629. doi:10.3389/fmed.2025.1569629.
|
| [15] |
陈典, 隆寰宇, 褚岚和, 等. 2026年GOLD慢性阻塞性肺疾病诊断、治疗、管理及预防全球策略更新要点解读[J]. 中国全科医学, 2026, 29(21): 2913-2932. doi:10.12114/j.issn.1007-9572.2026.0041.
|
| [16] |
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for prevention, diagnosis and management of COPD:2025 Report[R/OL].[2026-04-01]. https://goldcopd.org/2025-gold-report/.
|
| [17] |
Bhatt S P, Rabe K F, Hanania N A, et al. Dupilumab for COPD with blood eosinophil evidence of type 2 inflammation[J]. N Engl J Med, 2024, 390(24): 2274-2283. doi:10.1056/NEJMoa2401304.
|
| [18] |
Wedzicha J A, Seemungal T A. COPD exacerbations: defining their cause and prevention[J]. Lancet, 2007, 370(9589): 786-796. doi:10.1016/S0140-6736(07)61382-8.
pmid: 17765528
|
| [19] |
Cojocaru E, Haliga R E, Ene G B, et al. Mortality predictors in patients with severe COPD exacerbation[J]. J Clin Med, 2025, 14(9): 3028. doi:10.3390/jcm14093028.
|
| [20] |
Weng S, Huang Y, Wu X, et al. Construction of a nomogram model based on the pan-immune-inflammation value for prediction of adverse clinical outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease[J]. J Inflamm Res, 2025, 18: 14353-14364. doi:10.2147/JIR.S546857.
pmid: 41126977
|
| [21] |
刘建颖, 黄晨晨, 张培红, 等. 共病负担对气管插管的AECOPD患者28天院内死亡率的影响:基于MIMIC-Ⅳ数据库的回顾性队列研究[J]. 复旦学报(医学版), 2026, 53(3): 319-330, 368. doi:10.3969/j.issn.1672-8467.2026.03.003.
|
| [22] |
申思, 张志强. 血清RDW、BNP联合NPS评分对AECOPD住院患者院内临床转归的预测价值[J]. 海南医学, 2026, 37(8): 1076-1080. doi:10.3969/j.issn.1003-6350.2026.08.003.
|
| [23] |
袁丽杰, 郑贺, 张颖根, 等. SII、SIRI联合多项炎性因子对AECOPD合并社区获得性肺炎的预后评估[J]. 中华医院感染学杂志, 2026, 36(13): 2037-2041. doi:10.11816/cn.ni.2026-252830.
|
| [24] |
Rhee C K, Choi J Y, Park Y B, et al. Clinical characteristics and frequency of chronic obstructive pulmonary disease exacerbations in Korean patients: findings from the KOCOSS cohort 2012-2021[J]. J Korean Med Sci, 2024, 39(19): e164. doi:10.3346/jkms.2024.39.e164.
pmid: 38769923
|
| [25] |
朱鸣雷, 刘晓红. 共病老年患者的临床管理路径[J]. 中国临床保健杂志, 2024, 27(1): 9-13. doi:10.3969/J.issn.1672-6790.2024.01.003.
|
| [26] |
Zhu Y, Wang M, Gu X N, et al. Development and validation of the machine learning model for acute exacerbation of chronic obstructive pulmonary disease prediction based on inflammatory biomarkers[J]. Front Med (Lausanne), 2025, 12: 1616712. doi:10.3389/fmed.2025.1616712.
|